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Wang, Lixin, Vasantha Kolachala, Baljit Walia, Srividya Bala-
subramanian, Randy A. Hall, Didier Merlin, and Shanthi V.
Sitaraman. Agonist-induced polarized trafﬁcking and surface expres-
sion of the adenosine 2b receptor in intestinal epithelial cells: role of
SNARE proteins. Am J Physiol Gastrointest Liver Physiol 287:
G1100–G1107, 2004. First published July 15, 2004; doi:10.1152/
ajpgi.00164.2004.—Adenosine, acting through the A2b receptor, in-
duces vectorial chloride and IL-6 secretion in intestinal epithelia and
may play an important role in intestinal inﬂammation. We have
previously shown that apical or basolateral adenosine receptor stim-
ulation results in the recruitment of the A2b receptor to the plasma
membrane. In this study, we examined domain speciﬁcity of recruit-
ment and the role of soluble N-ethylmaleimide (NEM) attachment
receptor (SNARE) proteins in the agonist-mediated recruitment of the
A2b receptor to the membrane. The colonic epithelial cell line T84
was used because it only expresses the A2b-subtype adenosine recep-
tor. Cell fractionation, biotinylation, and electron microscopic studies
showed that the A2b receptor is intracellular at rest and that apical or
basolateral adenosine stimulation resulted in the recruitment of the
receptor to the apical membrane. Upon agonist stimulation, the A2b
receptor is enriched in the vesicle fraction containing vesicle-associ-
ated membrane protein (VAMP)-2. Furthermore, in cells stimulated
with apical or basolateral adenosine, we demonstrate a complex
consisting of VAMP-2, soluble NEM-sensitive factor attachment
protein (SNAP)-23, and A2b receptor that is coimmunoprecipitated in
cells stimulated with adenosine within 5 min and is no longer detected
within 15 min. Inhibition of trafﬁcking with NEM or nocodazole
inhibits cAMP synthesis induced by apical or basolateral adenosine by
98 and 90%, respectively. cAMP synthesis induced by foskolin was
not affected, suggesting that generalized signaling is not affected
under these conditions. Collectively, our data suggest that 1) the A2b
receptor is intracellular at rest; 2) apical or basolateral agonist stim-
ulation induces recruitment of the A2b receptor to the apical mem-
brane; 3) the SNARE proteins, VAMP-2 and SNAP-23, participate in
the recruitment of the A2b receptor; and 4) the SNARE-mediated
recruitment of the A2b receptor may be required for its signaling.
vesicle; adenosine; vesicle-associated membrane protein; T84 cells;
ADENOSINE IS A PURINE NUCLEOSIDE generated by ATP catabolism
at sites of tissue stress and injury, including inﬂammation,
ischemia, and tissue remodeling. Adenosine modulates a vari-
ety of cellular functions by interacting with speciﬁc cell surface
G protein-coupled receptors (A1, A2a, A2b, and A3). Under
pathological states, excess adenosine generated at inﬂamma-
tory sites can act as a potent proinﬂammatory or anti-inﬂam-
matory molecule, depending on the tissue and the adenosine
receptor on which it acts (4, 8, 26). For example, A2a receptors
in the synovial tissue have been shown to be involved in the
downregulation of inﬂammation (5, 26), whereas adenosine
acting through the A2b receptor is a key mediator of inﬂam-
mation in the lung (3) and during angiogenesis (1). In the
intestine, adenosine is generated in crypt abscesses during
active inﬂammation by the interaction of neutrophils with the
intestinal epithelia. Epithelial ectonucleotidases convert neu-
trophil-derived ATP into adenosine, which then acts through
the A2b receptor to induce vectorial chloride and IL-6 secre-
tion (8, 17, 28). Interestingly, the A2b receptor is the predom-
inant adenosine receptor expressed in the cecum and colon as
well as in both model colonic cell line T84 and in intact human
colonic mucosa (27, 32). Indeed, in the model colonic epithelia
T84 cells, the A2b receptor is the only adenosine receptor
expressed (7, 32).
We and others (2, 28, 32) have previously shown that
agonist stimulation of the apical or basolateral receptor induces
increase in cAMP levels, phophorylation of PKA, and activa-
tion of cAMP response-element binding protein, which medi-
ate apically directed chloride and IL-6 secretion. Interestingly,
we have demonstrated that the A2b receptor is recruited to the
plasma membrane and caveolar fraction on apical or basolat-
eral agonist stimulation and associates with ezrin, PKA, and
sodium hydrogen exchange regulatory factor-2 (NHERF-2/
E3KARP) (30), forming a multiprotein complex. This recruit-
ment is seen 5 min after receptor stimulation and parallels
cAMP synthesis and chloride secretion. However, the mem-
brane domain to which the A2b receptor is recruited and the
molecular events responsible for agonist-induced A2b receptor
trafﬁcking and membrane recruitment is not known.
In epithelial cells, the trafﬁcking and recruitment of proteins
from the intracellular trans-Golgi network to speciﬁed mem-
brane domains is mediated by a fusion machinery consisting of
several proteins collectively designated as the soluble N-eth-
ylmaleimide (NEM)-sensitive factor attachment protein recep-
tor (SNARE) proteins (24). Target SNARE (t-SNARE) deﬁnes
the target or acceptor membrane that interacts with several
vesicle SNAREs (v-SNAREs) expressed on different popula-
tions of approaching transport vesicles to form the SNARE
complex. Each transport vesicle contains a distinct v-SNARE
that pairs up with a cognate t-SNARE at the appropriate target
membrane. This speciﬁc interaction directs the vesicle to the
correct membrane with subsequent dissociation of the SNARE
complex by the ATPase activity of NEM-sensitive factor
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the synaptobrevin or vesicle-associated membrane protein
(VAMP) family. These proteins are 18-kDa membrane pro-
tein and have the COOH terminus toward the cytoplasm and
amino terminus spanning the membrane facing the vesicular
lumen. t-SNAREs are comprised of syntaxins and soluble
NEM sensitive factor attachment protein (SNAP). Syntaxins
are 35-kDa membrane proteins and SNAPs are 25-kDa
hydrophilic proteins associated with the plasma membrane via
several palmitoylated cysteine residues. The SNARE complex
is comprised of synaptobrevin or VAMP, syntaxin, and SNAP,
which bridge the vesicles to the respective plasma membrane.
Biochemical studies (6) have shown that the soluble coiled/
coil-forming domain of recombinant syntaxin, SNAP-25, and
VAMP forms a stable complex that is resistant to protease
digestion, SDS denaturation, and clostridial neurotoxin cleav-
age and is heat stable up to 90°C. Not surprisingly, SNARE
proteins are required for orderly assembly, function, and reg-
ulation of certain ion channels and receptors, such as CFTR
(16), H-K-ATPase (14, 15), aquaporin-2 (11, 25), and
GLUT4 (20). In this study, we investigated the membrane
domain speciﬁcity of agonist-induced membrane recruitment
of the A2b receptor and the involvement of SNARE proteins in
the trafﬁcking of the A2b receptor.
MATERIAL AND METHODS
Reagents. Adenosine and 5-(N-ethylcarboxamido)adenosine were
obtained from Research Biochemicals (Natick, MA). NEM and no-
codazole were obtained from Sigma (St. Louis, MO). Reagents for
SDS-PAGE and nitrocellulose membranes (0.45-m pores) were
from Bio-Rad (Hercules, CA). Anti-A2bR antibody was obtained
from Alpha Diagnostics (San Antonio, TX). We (30) have previously
demonstrated the speciﬁcity of this antibody to recognize A2b recep-
tor. Anti-synaptobrevin-2 (VAMP-2) and anti-SNAP-23 antibodies
were obtained from Synaptic Systems (Go ¨ttingen, Germany), anti-
Zonula occludens-1 (ZO-1) and anti-E-cadherin antibodies were ob-
tained from Zymed Laboratories (San Francisco, CA), and anti-actin
antibody were from Santa Cruz Biotechnology (Santa Cruz, CA).
Other antibodies including Rhodamine Red-X-conjugated AfﬁniPure
goat anti-mouse IgG, ﬂuorescein isothiocyanate-labeled goat anti-
rabbit antibody and horseradish peroxidase-conjugated Ig were ob-
tained from Jackson ImmunoResearch Laboratory (West Grove, PA).
OneStep RT-PCR kit was obtained from Qiagen (Valencia, CA), and
cAMP-Screen kit was from Applied Biosystems (Bedford, MA).
ATLGW64s a generous gift from Dr. Joel Linden (Adenosine Ther-
apeutics, University of Virginia, Charlottesville, VA).
Cell culture. T84 cells were grown and maintained in culture as
previously described (29) in a 1:1 mixture of DMEM and F-12
medium supplemented with penicillin (40 mg/l), ampicillin (8 mg/l),
streptomycin (90 mg/l), and 5% newborn calf serum. Conﬂuent stock
monolayers were subcultured by trypsinization. Experiments were
done on cells plated for 7 to 8 days on permeable supports of 0.33 or
4.5 cm2 (inserts). Inserts with rat-tail collagen-coated polycarbonate
membrane ﬁlter (0.4-m pore size; Costar, Cambridge, MA) rested in
wells containing media until steady-state resistance was achieved as
previously described (23). This permits apical and basolateral mem-
branes to be separately interfaced with apical and basolateral buffer,
a conﬁguration identical to that previously developed for various
microassays (23). The T84 cells had a high electrical resistance
(1,200–1,500 cm2). All experiments were performed on T84 cells
between passages 69 and 80.
Subcellular fractionation. Monolayers were washed in PBS,
scraped with a rubber policeman, and homogenized with a glass/
Teﬂon homogenizer in ice-cold buffer containing 250 mM sucrose, 10
mM Tris, pH 7.5, 1 mM PMSF, and 1 g/ml leupetin and pepstatin.
For the preparation of the low-speed pellet enriched in plasma mem-
brane and the high-speed pellet enriched in intracellular vesicle, the
cell suspension was centrifuged at 700 g for 10 min at 4°C. The
supernatant was centrifuged at 17,000 g for 45 min at 4°C. The
low-speed pellet was recovered in PBS buffer and the supernatant was
spun at 200,000 g at 4°C. The ﬁnal pellet (high-speed) was recovered
in PBS (11, 18). Protein quantitation was done by using the Lowry
method (Bio-Rad).
For studies on A2b receptor localization, plasma membrane frac-
tion was prepared from T84 cells plated in 4.5 cm2 inserts as described
(30, 31). Brieﬂy, each insert was washed twice with 5 ml of buffer
containing 0.25 M sucrose, 1 mM EDTA, 20 mM tricine pH 7.8
(buffer A), and the cells were collected by scraping in buffer A. The
cells were resuspended in buffer A, homogenized by using a Teﬂon
homogenizer, and centrifuged at 1,000 g for 10 min. The postnuclear
fraction was layered on the top of 23 ml of 30% percoll in buffer A and
was centrifuged at 84,000 g for 30 min. The plasma membrane
fraction was a visible band 5.7 cm from the bottom of the centrifuge
tube. Protein quantitation was done, and 20 g protein from each
fraction was subjected to Western blot analysis.
Confocal microscopy. Monolayers of cells were washed in HBSS,
ﬁxed in buffered formaldehyde for 20 min, incubated with respective
primary antibodies overnight in a humidity chamber, washed with
HBSS, and subsequently incubated with ﬂuorsceinated secondary
antibodies (Jackson ImmunoResearch). Monolayers were also coun-
terstained with rhodamine/phalloidin to visualize actin. Monolayers,
mounted in p-phenylenediamine/glycerol (1:1) were analyzed by
confocal microscopy (Zeiss dual-laser confocal microscope) as de-
scribed (30). With the use of actin staining, the apical-most surface of
the cell was marked as 0 m and the basolateral surface was marked
at the level of actin stress ﬁber (18.7 m from the top of the cell).
The x-y sections taken at 1.2 m from the top (above the level of
tight junction) and at the level of actin stress ﬁber were used for
marking apical and basolateral surfaces, respectively.
Electron microscopy. Cells grown on ﬁlters were ﬁxed with 4%
paraformaldehyde in 0.1 M PBS (pH. 7.4) for 20 min followed by 2%
paraformaldehyde in the same buffer overnight. Immunogold labeling
was carried out on ﬁlters removed from their holders before embed-
ding (35). Cells were washed thoroughly with PBS and then placed in
0.1% sodium borohydrade in PBS for 15 min to reduce residual
aldehyde. After being washed several times with PBS, cells were
permeabilized for 10 min using 0.05% Triton 100-X in PBS. Cells
were then incubated with blocking buffer containing 5% normal goat
serum, 5% BSA, and 0.1% cold water ﬁsh-skin gelatin (in PBS) for 30
min at room temperature. Cells were incubated in primary antibody
(anti-A2b receptor) or isotype control antibody (rabbit IgG) diluted
with PBS containing 0.2% acetylated BSA from Aurion (Wegenin-
gen, The Netherlands) at 1:100. After being washed several times,
cells were incubated for 12 h at 4°C in goat anti-rabbit ultrasmall gold
conjugates (Aurion). After being washed with PBS/BSP-c and PBS,
cells were ﬁxed with 2.5% glutaraldehyde in 0.1 M PBS before silver
enhancement. Silver enhancement of ultrasmall gold particles were
performed by using Aurion R-gent SE-EM kit following the manu-
facturer’s instructions. Sections were ﬁxed with 0.5% osmium tetrox-
ide in 0.1 M PBS for 15 min. Cells were then dehydrated and
embedded in epoxy resin for electron microscopy. Ultrathin sections
were cut perpendicular to the ﬁlter surface at 70 nm and examined on
a transmission electron microscope (model H-7500; Hitachi, Pleasan-
ton, CA)
Cell surface expression assays. Cell surface expression assays were
done as described (34). Brieﬂy, monolayers of T84 were washed with
PBS and then incubated in the absence and presence of agonist for 5
min. The cells were then rinsed in PBS and ﬁxed with 4% parafor-
maldehyde in PBS and blocked with blocking buffer (2% nonfat dry
milk in PBS, pH 7.4) for 30 min. The ﬁxed cells were then incubated
with primary antibody (1:400) in blocking buffer for1ha troom
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ing buffer and incubated for1ha troom temperature with horseradish
peroxidase-conjugated secondary antibody (Amersham Biosciences,
Piscataway, NJ). Finally, the cells were incubated with supersignal
Elisa Pico enhanced chemiluminescence (ECL) reagent (Pierce, Rock-
ford, IL). The luminescence, which corresponds to the amount of
receptor on the cell surface, was determined by using TD 20/20
luminometer (Turner Designs, Sunnyvale, CA).
Cell surface biotinylation. Apical or basolateral sides of the ﬁlter-
grown monolayers were biotinylated by using sulfosuccinidobiotin
(s-NHS-biotin; Pierce) as previously described (30). Filter-grown
cells were rinsed twice with PBS supplemented with 0.1 mM CaCl2
and 1 mM MgCl2. Basolateral or apical sides of the monolayers were
incubated with freshly prepared sulfosuccinimidobiotin (Pierce) di-
luted in the same solution (0.5 mg/ml) for 30 min at room tempera-
ture. The reaction was quenched with ice-cold 50 mM NH4Cl, and
cells were lysed with a solution of 1% (wt/vol) Triton X-100 in 20
mM Tris, pH 8.0, 50 mM NaCl, 5 mM EDTA, and 0.2% (wt/vol) BSA
supplemented with protease inhibitors. The protein solution was
diluted with 1 ml of lysis buffer and then incubated with streptavidin-
agarose (Pierce) for 12 h at 4°C to bind biotinylated proteins. The
protein solution was then boiled in sample buffer. Proteins were
separated by SDS-PAGE and transferred overnight at 4°C to nitro-
cellulose membranes. The blots were blocked 1 h with 5% nonfat dry
milk in blocking buffer. After being washed with blocking buffer, the
blots were incubated for1ha troom temperature with 1:1,000 dilution
of anti-A2b receptor antibody. They were further incubated for 1 h at
room temperature with anti-rabbit horseradish peroxidase-conjugated
antibody diluted 1:1,000 and probed by using an ECL system (Am-
ersham Pharmacia Biotech) (30).
SDS-PAGE and Western blot analysis. Cells were lysed with PBS
containing 1% Triton X-100 and 1% Nonidet P-40 (vol/vol), protease
inhibitor mixture (Roche Molecular Biochemicals, Alameda, CA),
EDTA, SDS, sodium orthovanadate, and sodium ﬂuoride. SDS-PAGE
was performed according to the Laemmli procedure using a 10%
acrylamide gel. Proteins were electrotransferred to nitrocellulose
membranes and probed with primary antibody (diluted 1:1,000).
Membranes were then incubated with corresponding peroxidase-
linked secondary antibody diluted 1:2,000, washed, and subsequently
incubated with ECL reagents (Amersham Biosciences) before expo-
sure to high performance chemiluminescence ﬁlms (Amersham Bio-
sciences). For molecular ratio (Mr) determination, polyacrylamide
gels were calibrated by using standard proteins (Bio-Rad) with Mr
markers within the range of 7,700 to 214,000. The band intensity of
the Western blot was quantitated by using a gel documentation system
(Alpha Innotech, San Leandro, CA).
Immunoprecipitation. To show that vesicles dock at the apical
plasma membrane, we set up an immunoprecipitation assay on the
basis of the observation that SNAP-23 is found at the apical plasma
membrane. NEM was used to stabilize the complex as described (10).
The cells were stimulated with apical or basolateral adenosine for 5 or
15 min. Before the cells were harvested, they were treated in PBS with
1 mM NEM 15 min on ice; NEM was quenched by 2 mM DTT for 15
min on ice. The cells were then washed in PBS and further incubated
in culture medium for 30 min at 37°C. The cells were then lysed in
buffer containing 50 mM TrisHCL, 150 mM NaCl, 10 mM EDTA,
1% Triton X-100, and protease inhibitor mixture (Roche Molecular
Biochemicals). The lysates were centrifuged at 12,000 g for 10 min at
4°C, and the resulting supernatants were subjected to immunoprecipi-
tation as described above. The supernatants were incubated overnight
at 4°C with anti-SNAP-23 (1:400) and then 50 l of protein G bead
suspension was added to the mixture and incubated4ha t4 °C. The
complexes were collected by centrifugation at 12,000 g for 2 min.
Western blot analysis was performed by using anti-VAMP-2 or
anti-syntaxin-3 (1:1,000).
RNA isolation, RT-PCR, and cDNA sequencing. Total RNA was
extracted from monolayers of T84 cells by the TRIzol extraction
method (TRI reagent, Molecular Research Center, Cincinnati, OH).
The RNA was then used to amplify fragments of the cDNA of
VAMP-2 and SNAP-23 by RT-PCR employing Qiagen OneStep
RT-PCR kit. The primers were designed on the basis of the VAMP-2
and SNAP-23 nucleotides sequences available in the GenBank data-
base. VAMP-2 (sense: 5-taacaggagactgcagcaga-3, antisense: 5-gat-
gatgaggatgatggcgc-3) SNAP-23 (sense: 5-ggtttagccattgagtctca-3,
antisense: 5-ctgcccacttgagtcaggtt-3). A positive control was per-
formed by using primers speciﬁc for GAPDH (sense: 5-gccaaggt-
catccatgacaac-3, antisense: 5-gtccaccaccctgttgctgta-3). OneStep
RT-PCR was performed with the following program: 50°C for 30
min, 95°C for 15 min followed by 29 cycles, each cycle consisting of
95°C for 45 s, 50°C for 45 s, 72°C for 1 min.
cAMP measurement. T84 cells were pretreated with NEM (100
M) for 30 min or nocodazole (10 g/ml) for 12 h, and then washed
and stimulated with apical or basolateral adenosine (100 M, respec-
tively) or forskolin (100 M). cAMP measurements were done in
whole cell lysates using a competitive cAMP immunoassay kit (Ap-
plied Biosystems). Luminescence was read by using Luminoskan
Ascent (Thermo Lab Systems, Needham Heights, MA).
Statistical analysis. The data are presented as means  SD.
Statistical analysis was performed by using unpaired Student’s t-test.
A P value  0.05 was considered statistically signiﬁcant.
RESULTS
Majority of A2b receptor is intracellular at rest. We studied
the localization of A2b receptor at rest using cell fractionation,
cell surface biotinylation, and electron microscopy. Puriﬁed
plasma membranes were isolated from conﬂuent monolayers of
T84 cells plated on inserts as described in MATERIALS AND
METHODS. As seen in Fig. 1A, top, a small amount of A2b
receptor is detected in the plasma membrane fraction at rest,
whereas the majority of A2b receptor is detected in the intra-
cellular compartment. We also performed domain-speciﬁc bi-
otinylation to conﬁrm the localization of the A2b receptor. To
this end, polarized monolayers of T84 cells were subjected to
biotinylation and immunoprecipitated with avidin beads. West-
ern blot analysis was performed on the immunoprecipitate and
the supernatant (nonbiotinylated and intracellular proteins)
using anti-A2b receptor antibody as described in MATERIALS
AND METHODS. Small quantities of receptor were detected in the
apical and basolateral membrane and consistent with earlier
reported data. There were more receptors on the basolateral
membrane compared with apical membrane (Fig. 1A, bottom).
However, the majority of the receptor was detected in the
nonbiotinylated fraction suggesting that the receptor was in-
tracellular. To further conﬁrm the intracellular localization of
the receptor, we performed electron microscopy of the T84
monolayer. As seen in Fig. 1B and consistent with the bio-
chemical data, the majority of the A2b receptor appeared to be
intracellular.
The A2b receptor is recruited to the apical membrane upon
agonist stimulation. We used two approaches to determine to
which membrane the A2b receptor is recruited upon stimula-
tion. First, we examined the distribution of the receptor using
a quantitative luminometer-based assay. T84 cells plated on a
membrane-permeable support were stimulated with apical or
basolateral adenosine for 5 min followed by quantitation of
A2b receptor recruited to the membrane as described in MATE-
RIALS AND METHODS. As shown in Fig. 2A, there was a two- and
threefold increase, respectively, of the A2b receptors in the
apical membrane (apical stimulation, 200  25%; basolateral
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cells, P  0.05), whereas there was no increase in the baso-
lateral receptors (apical stimulation, 70  20%; basolateral
stimulation, 100  10% compared with unstimulated cells).
Secondly, we used domain-speciﬁc biotinylation to determine
the membrane aspect of the polarized cells to which the A2b
receptor is recruited upon agonist stimulation. As shown in Fig.
2B (lanes 1 and 2), A2b receptor expression at the basolateral
membrane is higher than apical membrane in unstimulated
cells. This is consistent with our previous data (30) showing
that the density of the A2b receptor is signiﬁcantly higher at the
basolateral membrane. As assessed by scanning densitometry
of the bands (Fig. 2B, bottom), apical or basolateral adenosine
stimulation for 5 min resulted in a two- and threefold increase,
respectively, in apical receptor density (Fig. 2B, lanes 2 and 3),
whereas the basolateral receptor levels remained unchanged
(Fig. 2B, lanes 5 and 6). These data demonstrate that the A2b
receptor is recruited to the apical membrane upon agonist
stimulation.
A2b receptor is recruited to the vesicle and plasma mem-
brane fractions upon agonist stimulation. We then examined
whether the recruitment of the A2b receptor to the apical
membrane involves trafﬁcking through vesicles and whether
the SNARE complex is involved in this process. High density
(enriched in intracellular vesicles) and low density (enriched in
plasma membrane) cell fractions were isolated by differential
centrifugation. As seen in Fig. 3, top, A2b receptor is not
detected in the vesicles in the unstimulated cells. Apical or
basolateral stimulation with adenosine resulted in an enrich-
ment of the receptor in the vesicle and plasma membrane
fractions. VAMP-2 used as a marker for vesicles is enriched in
the vesicles and did not change upon adenosine stimulation.
Na-K-ATPase used as a marker for plasma membrane
fraction is enriched in the membrane fraction and did not
Fig. 2. A2bR is recruited to the apical membrane upon agonist stimulation. A:
monolayers were incubated with apical (Ap Ado; AA) or basolateral (Bs Ado;
BA) adenosine (100 M) for 5 min and then with anti-A2bR antibody as
described in MATERIALS AND METHODS. Bars show %increase in ﬂuorescence
compared with unstimulated monolayer (means  SD; n  3; *P  0.05
compared with unstimulated monolayer). B: monolayers were treated with AA
or BA (100 M) or unstimulated (Ctl) for 5 min and then subjected to cell
surface biotinylation (apical or basolateral biotinylation). Biotinylated proteins
were immunoprecipitated with avidin-conjugated beads, subjected to Western
blot analysis, and immunostained by using anti-A2bR antibody. The imuno-
reactive bands were quantitated by using scanning densitometry and the bars
represent fold change compared with unstimulated cells. The experiment was
repeated 3 times with 3 ﬁlters per condition (means  SD; n  3; *P  0.05
compared with unstimulated monolayer).
Fig. 1. The majority of the A2b receptors (A2bR) are intracellular. A, top:
plasma membrane fraction (PM) and postnuclear supernatant (PN) were
subjected to Western blot analysis and detected with anti-A2bR antibody.
Bottom, monolayers were subjected to cell surface biotinylation (A, apical; B,
basolateral) as described in MATERIALS AND METHODS. Biotinylated proteins
were immunoprecipitaed with avidin-conjugated beads. The immunoprecipi-
tate as well as the supernantant were subjected to Western blot analysis and
immunostained by using anti-A2bR antibody. B: electron microscopy showing
the intracellular localization of the A2bR (arrows show intracellular mem-
brane; Left, isotype control antibody; right, A2bR antibody. N, nucleus.
G1103 A2B RECEPTOR TRAFFICKING
AJP-Gastrointest Liver Physiol • VOL 287 • NOVEMBER 2004 • www.ajpgi.orgchange with adenosine stimulation. 	-actin, used as a control
protein, also did not show any change with adenosine stimu-
lation (Fig. 3A, bottom). As shown in Fig. 3, bottom, there is no
change in the total A2b receptor detected in the postnuclear
supernatent. These data suggest that in adenosine-stimulated
cells, the A2b receptor trafﬁcked from the intracellular pool to
the vesicular and membrane compartment.
To see whether adenosine stimulation is speciﬁc for the
translocation of the A2b receptor to the plasma membrane, we
used forskolin, a direct stimulator of adenylate cyclase or
vasointestinal peptide (VIP), a receptor-mediated inducer of
cAMP signal. Interestingly, as shown in Fig. 4, forskolin (10
M, 5 min) but not VIP (10 nM, 5 min) was able to induce A2b
receptor translocation to the plasma membrane (lanes 4 and 7,
respectively). At this time point, both VIP and forskolin re-
sulted in increased intracellular cAMP (data not shown). A2b
receptor antagonist ATLGW64s was able to inhibit the agonist-
induced A2b receptor translocation to the membrane (Fig. 4,
lanes 5 and 6). As a marker for plasma membrane, Na-K-
ATPase is shown at Fig. 4, bottom.
VAMP-2 is present in the intracellular compartment and
SNAP-23 is enriched in the plasma membrane fraction. Be-
cause of the involvement of vesicles in the A2b receptor
recruitment to the membrane, we investigated the possible role
of putative vesicle-targeting proteins (SNAREs) in the ade-
nosine-regulated trafﬁcking of A2b receptor-containing vesi-
cles to the apical plasma membrane. We carried out immuno-
blotting, confocal microscopy, and RT-PCR experiments in
T84 cells to evaluate the type and distribution of SNARE
proteins in T84 cells. With the use of semiquantitative RT-
PCR, we showed that VAMP-2 and SNAP-23 are expressed in
T84 cells, and the transcript levels are not altered by adenosine
treatment (Fig. 5A). Western blot analysis was carried out by
using speciﬁc antibodies to analyze the protein expression of
the detected SNAREs, VAMP-2, and SNAP-23. T84 cells were
fractionated to separate plasma membrane-enriched fraction
and a membrane fraction enriched in intracellular vesicles.
VAMP-2 stained an 18-kDa band in vesicle fraction and was
not detected in the membrane fraction. In contrast, SNAP-23
was found enriched in the plasma membrane fraction (Fig. 5B).
Furthermore, as seen in Fig. 5C, VAMP-2 is predominantly
expressed in the subapical domain of the cells at the level of
E-cadherin (marker of adherence junction), whereas SNAP-23
(Fig. 5D) is expressed both in the apical domain at the level of
the tight junction (as evidenced by the ZO-1 staining marker of
the tight junction), as well as in the basolateral domain (colo-
calization of SNAP-23 with E-cadherin).
SNAP-23 associates with VAMP-2 and syntaxin-3 upon
agonist stimulation. To demonstrate that exocytic vesicles
containing A2b receptor and VAMP-2 dock with membrane-
associated SNAP-23, we performed immunoprecipitation ex-
periments. As shown in Fig. 6, immunoprecipitation with
SNAP-23 and Western blot analysis with VAMP-2 (middle),
SNAP-23 (left), or A2b receptor (right) yielded a complex at
85 kDa. This complex was detected 5 min after apical or
basolateral adenosine stimulation was not present in unstimu-
lated cells and was not detected 15 min after adenosine stim-
ulation. Immunoprecipitation was also performed with anti-
VAMP-2 antibody and a complex at 85 kDa was seen on
Western blot analysis using anti-SNAP-23, anti-VAMP-2, or
anti-A2b receptor antibody (data not shown).
A2b receptor signaling requires vesicle trafﬁcking. To see
whether the signaling of the A2b receptor requires vesicular
trafﬁcking and recruitment of the receptor to membrane, we
studied the effect of an inhibitor of NEM-sensitive factor and
nocodozole (inhibitor of microtubule polymerization) pretreat-
ment on cAMP levels stimulated by apical or basolateral
adenosine. T84 cells were pretreated with NEM for 30 min as
described in MATERIALS AND METHODS. Cells were stimulated
with apical or basolateral adenosine and cAMP was measured
by using a ﬂuorimetric assay. Apical or basolateral adenosine
increased cAMP levels by approximately seven- and thirtyfold,
respectively (unstimulated, 1.05  0.02; apical adenosine,
7.80  0.24; basolateral adenosine, 31.5  5.4 pmol/106 cells,
Fig. 4. Effect of vasointestinal peptide (VIP) and forskolin (Fsk) on the
recruitment of A2bR to the plasma membrane. Monolayers were incubated
with AP Ado, Bs Ado, ATLGW64S (G)  Ap Ado, G  Bs Ado (100 M,
respectively), Fsk (10 M), or VIP (1 nM) for 5 min. Plasma membrane
fractions were then subjected to Western blot analysis with anti-A2bR anti-
body as described in MATERIALS AND METHODS.N a -K-ATPase was used as
a plasma membrane marker.
Fig. 3. A2bR is recruited to the vesicle and plasma membrane fractions upon
agonist stimulation. Cell fractionation of ﬁlter-grown T84 monolayers was
performed as described in MATERIALS AND METHODS. Samples from vesicle (V)
or membrane (M) fractions were subjected to Western blot analysis using
anti-A2bR antibody. Blots were stripped and probed for b-actin to conﬁrm
equal protein loading. Na-K-ATPase was used as a plasma membrane
marker. Vesicle-associated membrane protein (VAMP)-2 was used as a marker
of the vesicle fraction. The results are representative of 3 independent exper-
iments. Postnuclear supernatent from control (ctl), Ap Ado-, or Bs Ado-treated
monolayers were subjected to Western blot analysis using anti-A2bR antibody
(bottom). S, supernatant; P, pellet.
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levels induced with apical or basolateral adenosine by 98 and
90%, respectively (NEM  apical adenosine, 1  0.021;
NEM  basolateral adenosine, 2.7  0.012; NEM alone
1.05  0.02 pmol/106 cells, respectively). To ensure that NEM
did not block signaling in general, forskolin was used as a
stimulator of cAMP synthesis. NEM pretreatment did not
inhibit forskolin (100 M)- induced cAMP synthesis (forskolin
117  1.2, NEM  forskolin 110.4  15.9) (Fig. 7). Given the
possibility that NEM may perturb receptor function through
nonspeciﬁc cysteine acetylation, we used an alternate approach
to inhibit microtubule-dependent trafﬁcking by using nocoda-
zole. As shown in Fig. 7, pretreatment with nocodazole inhib-
ited cAMP increase induced by adenosine by 75 and 65%,
respectively (nocodozole  apical adenosine 1.95  0.32,
nocodazole  basolateral adenosine 11.5  6.4 pmol/106 cells,
respectively) The foregoing data collectively suggest that the
recruitment of A2b receptor mediated by vesicular trafﬁcking
may be required for receptor signaling.
DISCUSSION
We (30) have previously shown that apical or basolateral
adenosine receptor stimulation results in the recruitment of the
A2b receptor to the plasma membrane and caveolar fraction. In
this study, we used human colonic epithelial cell line T84 to
examine the domain speciﬁcity and the underlying mechanism
by which the A2b receptor is recruited to the membrane upon
agonist stimulation. We ﬁrst demonstrate that the A2b receptor
is localized intracellularly at rest. This is a novel ﬁnding,
because G protein-coupled receptors are characteristically lo-
calized in the plasma membrane and intracellular localization
requiring membrane translocation for its function is atypical
(19). Because the A2b receptor mediates the upregulation of
adenosine-induced electrogenic chloride secretion (secretory
diarrhea) and IL-6 (proinﬂammatory cytokine) secretion, it is
conceivable that its intracellular localization may be function-
ally relevant to curb inappropriate stimulation. In the case of
aquaporin and other channels and transporters, sequestration to
Fig. 5. Localization of SNAP-23, VAMP-2, and
syntaxin-3 in T84 cells. A: RT-PCR ampliﬁcation
of SNAP-23 and VAMP-2. Total RNA from po-
larized monolayers was subjected to reverse tran-
scription followed by PCR ampliﬁcation using
SNAP-23, VAMP-2, and GAPDH primers. Bands
corresponding to VAMP-2 (244 bp, VAMP),
SNAP-23 (398 bp, SNAP), and GAPDH (497 bp
GDH) are shown. B: membrane fractions enriched
in plasma membrane (M) or vesicles (V) (20 g
per lane) were probed with anti-SNAP-23 or anti-
VAMP-2 antibody. Immunoreactive bands were
revealed with enhanced chemiluminescence (ECL
Plus; Amersham). The results are representative of
two independent experiments. C–D: confocal im-
aging of VAMP-2 and SNAP-23, respectively.
Monolayers were ﬁxed and stained with either
rabbit polyclonal anti-VAMP-2 or anti-SNAP-23
antibody followed by FITC secondary antibody
(green, a and c). Monolayers were also stained
with rhodamine- anti-Zonula occludens-1 (ZO-1)
(b, red is marker of tight junction representing
apical domain) or rhodamine anti-E-Cadherin (d,
red is marker of adherens junction representing
subapical or lateral membrane domain). En face
(x-y) sections are shown here. VAMP-2 is seen in
intracellular organelles localized to the lateral
plane (Fig. 5C, d), and SNAP-23 is seen both at
the apical domain and lateral membrane (Fig. 5D,
b and d).
Fig. 6. VAMP-2 associates with SNAP-23
upon adenosine stimulation. Monolayers were
treated with vehicle (Ctl, lane 1), Ap Ado or
Bs Ado for 5 (lanes 2 and 3)o r1 5m i n( lanes
4 and 5). Whole cell lysates were subjected to
immunoprecipitation (IP) with rabbit poly-
clonal anti-SNAP-23 and detected with rabbit
polyclonal anti-SNAP-23, anti-VAMP-2, or
anti-A2b antibody, respectively, on a Western
blot of the immunoprecipitates. Blots are rep-
resentative of 3 independent experiments with
3 ﬁlters per condition. IB, immunoblot.
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ﬂuid and electrolyte balance (aquaporin) and to prevent dele-
terious consequences of inappropriate receptor stimulation
(Na-K-ATPase) (11, 25). The intracellular compartment in
which the A2b receptor is localized is currently being investi-
gated in our laboratory. The results reported in this study are
based on the speciﬁcity of anti-A2b receptor antibody. Al-
though, we (30) have shown previously that the A2b receptor
antibody used in this study speciﬁcally recognizes the A2b
receptor, we recognize that it is possible that nonspeciﬁc
immunoreactivity could be inﬂuenced by treatment of cells
with adenosine, which is known to cause shape changes and
likely changes in cytoskeletal organization.
Our data show that the A2b receptor is recruited to the apical
membrane domain whether the cells are stimulated with apical
or basolateral adenosine. Interestingly, the A2b receptor cou-
ples to apically located CFTR to induce chloride secretion (12).
In addition, adenosine-induced IL-6 (28), as well as ﬁbronectin
secretion (unpublished observation), are polarized to the apical
surface. The apical recruitment may thus be relevant to the
polarized secretion of IL-6 and ﬁbronectin, which may use
channels, such as CFTR for secretion. Our data further dem-
onstrate that vesicular trafﬁcking is involved in the recruitment
of the A2b receptor to the membrane. We therefore analyzed
the expression and role of various SNARE proteins known to
mediate vesicle membrane trafﬁcking. With the use of confocal
microscopy and cell fractionation, we show that VAMP-2 is
present in the subapical domain and is enriched in the vesicular
fraction, whereas SNAP-23 and syntaxin-3 are present in the
apical domain and in the lateral membrane enriched in the
plasma membrane fraction. These data are consistent with
earlier work demonstrating that VAMP-2 is associated with
vesicles typical of a v-SNARE, and SNAP-23 and syntaxin-3
are associated with the apical plasma membrane more typical
of a target SNARE (10, 24). Upon agonist stimulation, the A2b
receptor is enriched in vesicle fraction containing VAMP-2,
suggesting that VAMP-2 may play a role in the recruitment of
the receptor to the apical membrane. VAMP-2 staining is
detected in the apical domain on adenosine stimulation con-
sistent with the translocation of vesicles containing VAMP-2
and A2b receptor. Furthermore, our data show that in cells
stimulated with adenosine, VAMP-2, SNAP-23, and A2b re-
ceptor form a complex suggesting that VAMP-2-containing
vesicles dock with SNAP-23 at the apical membrane. Our
NEM and nocodozole data suggest that the trafﬁcking of A2b
receptor to the membrane may be important for its signaling.
The signal or signaling event required for the recruitment of
the A2b receptor is not known. Adenosine has been shown to
diffuse passively across the apical membrane, whereas a nu-
cleoside transporter is required for its transport across the
basolateral membrane (22). It is conceivable that adenosine
uptake, by passive diffusion or active transport, can bind to
intracellular A2b receptor resulting in its signaling and mem-
brane recruitment. Preliminary experiments using a potent
adenosine uptake inhibitor-S-(4-nitrobenzyl)-6-thioinosine, an
inhibitor of adenosine transport, did not affect A2b receptor
signaling. These data suggest that adenosine may stimulate
membrane receptors, resulting in increased cAMP, which in
turn can initiate recruitment of additional receptors to the
membrane. It has been shown that cAMP mediates protein
trafﬁcking to the apical but not the basolateral cell surface by
modulating sialylation of proteins and vesicle budding from the
trans-Golgi network (13). In the case of the CFTR and aqua-
porin-2, cAMP is sufﬁcient to induce the channel or receptor
translocation to the membrane. Moreover, PKA has been
demonstrated to directly interact with VAMP-2 or syntaxin 4
(9) to modulate the formation of the SNARE complex.
It can be argued that the recruitment of receptors to the
vesicle fraction may relate to agonist-mediated desensitization,
which is a characteristic feature of G protein-coupled receptors
(GPCRs). It is known that GPCRs undergo early desensitiza-
tion, which occurs within minutes and involves receptor phos-
phorylation and conformational changes and a late desensiti-
zation that occurs within hours and involves receptor seques-
tration to lysosomes or endosomes for degradation or
recycling, respectively. We have previously shown that early
desensitization of the A2b receptor begins 20 min after aden-
osine stimulation and that late desensitization occurs 6 h after
adenosine stimulation. Matharu et al. (21) have subsequently
shown that early desensitization of the A2b receptor involves
phosphorylation of serine residue at the COOH terminus,
which occurs within1ho freceptor stimulation. Our data show
that the time course of A2b receptor signaling measured as
increased cAMP or as an increase in short-circuit current (33)
parallels the recruitment of the receptor-to-plasma membrane
fractions and does not ﬁt with the time course of desensitiza-
tion but rather is consistent with membrane recruitment that
may be required for receptor signaling.
We have previously shown that the A2b receptor, upon
apical or basolateral stimulation, exists in association with
E3KARP/NHERF-2, ezrin, and PKA RII
. These data are
consistent with the close proximity of the receptor and its
signaling complex to CFTR, resulting in chloride secretion. In
the present study, we show that the A2b receptor is recruited to
the apical membrane upon agonist stimulation, and the SNARE
proteins play a functional role in the recruitment of the A2b
receptor. Taken together, our data show that the A2b receptor
recruited to the apical membrane by SNARE proteins may be
anchored there with its signaling complex via its interaction
with NHERF-2 and ezrin.
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treated with N-ethylmaleimide (NEM) (100 M) for 30 min or nocodazole (10
g/ml for 12 h) and then stimulated with AA (100 M), BA (100 M) or Fsk
(100 M) for 5 min. cAMP was measured in cell lysates as described in
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